The companies moving fast treat OS updates as strategic moments. The ones struggling now will struggle with every platform ...
BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused ...
Walt Disney Co. is investing $1 billion in OpenAI under a new commercial partnership with the ChatGPT and Sora developer. The three-year licensing agreement will allow users of Sora, OpenAI's ...
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to ...
An update from Phoenix New Media ( (FENG)) is now available. On November 5, 2025, Phoenix New Media Limited announced a new program license agreement with Phoenix Satellite Television Holdings Limited ...
A “software licensing troll” is a term coined by Michael Corey and Dean Bolton, cofounder and chief architect of LicenseFortress, in collaboration with Art Beeman and Joel Muchmore of Beeman and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback